-
Consmr offers new kind of product review website
NEW YORK — Review websites have become an essential tool for the discriminating consumer, so it's only natural that one would crop up for consumer goods.
Consmr provides ratings for product categories ranging from consumables and personal care to hair care and household items, allowing users to give products between one and five stars. Advertising Age described it as a consumer product version of restaurant review site Yelp.
-
FDA approves Nulojix
SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for preventing organ rejection in kidney transplant patients, the agency said Wednesday.
The FDA approved Bristol-Myers Squibb’s Nulojix (belatacept), for preventing acute rejection in adult patients. The drug is approved for use with other immune system-suppressing drugs, specifically Novartis’ Simulect (basiliximab), Genentech’s CellCept (mycophenolate mofetil) and corticosteroids.